Brief: Biofrontera Inc Fourth Quarter 2022 Total Revenues $10.1 Mln
March 8 (Reuters) - Biofrontera Inc BFRI.O :
* BIOFRONTERA INC - FOURTH QUARTER 2022 TOTAL REVENUES OF
$10.1
MILLION, COMPARED WITH $9.2 MILLION IN THE FOURTH QUARTER OF
2021
* BIOFRONTERA INC - NET LOSS FOR THE FOURTH QUARTER OF 2022
WAS
$2.8 MILLION COMPARED WITH A NET LOSS OF $14.5 MILLION FOR THE
FOURTH QUARTER OF 2021
Source: (shorturl.at/xzJS3)
Further company coverage: BFRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biofrontera
See all newsBrief: Biofrontera Submits Supplemental New Drug Application To FDA To Expand Ameluz® Red Light Pdt To Actinic Keratoses On The Full Body
Biofrontera Inc reports results for the quarter ended June 30 - Earnings Summary
Biofrontera Q2 revenue rises on higher volume, pricing
Biofrontera Inc expected to post a loss of 10 cents a share - Earnings Preview
Biofrontera Q1 revenue rises on higher Ameluz sales